Jim Simons’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-120,000
Closed -$1.64M 3309
2025
Q4
$1.64M Buy
+120,000
New +$2.22M ﹤0.01% 1989
2025
Q3
Sell
-43,900
Closed -$524K 3553
2025
Q2
$524K Sell
43,900
-7,100
-14% -$89.4K ﹤0.01% 2802
2025
Q1
$606K Buy
+51,000
New +$793K ﹤0.01% 2662
2024
Q4
Sell
-48,900
Closed -$548K 3609
2024
Q3
$548K Sell
48,900
-120,800
-71% -$1.16M ﹤0.01% 2747
2024
Q2
$915K Buy
169,700
+144,088
+563% +$834K ﹤0.01% 2375
2024
Q1
$174K Buy
+25,612
New +$179K ﹤0.01% 3260
2023
Q1
Sell
-49,337
Closed -$418K 4016
2022
Q4
$418K Buy
+49,337
New +$468K ﹤0.01% 3047
2022
Q2
Sell
-155,000
Closed -$1.61M 4257
2022
Q1
$1.61M Buy
155,000
+71,800
+86% +$653K ﹤0.01% 2390
2021
Q4
$934K Buy
+83,200
New +$1.25M ﹤0.01% 2698
2021
Q3
Sell
-47,700
Closed -$911K 3515
2021
Q2
$911K Sell
47,700
-27,900
-37% -$539K ﹤0.01% 2710
2021
Q1
$1.6M Buy
75,600
+22,552
+43% +$483K ﹤0.01% 2367
2020
Q4
$843K Buy
53,048
+11,100
+26% +$99.6K ﹤0.01% 2588
2020
Q3
$229K Sell
41,948
-8,652
-17% -$38.2K ﹤0.01% 3069
2020
Q2
$180K Buy
50,600
+22,300
+79% +$82.9K ﹤0.01% 3181
2020
Q1
$101K Buy
+28,300
New +$139K ﹤0.01% 3226

Other funds holding CLPT

Jim Simons's CLPT Position: Q1 2026 in Review

Jim Simons sold out of ClearPoint Neuro (CLPT) in Q1 2026, closing a stake of 120,000 shares — an estimated $1.64M sold.

Jim Simons first reported a position in CLPT in Q1 2020 and held it in 15 quarters. The position peaked at $1.64M in Q4 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • Jim Simons reported no remaining ClearPoint Neuro position as of Q1 2026 after selling out during the quarter.
  • Jim Simons sold 120,000 ClearPoint Neuro shares in Q1 2026, an estimated $1.64M.
  • Jim Simons first reported a position in ClearPoint Neuro in Q1 2020 and held it in 15 quarters.
  • Jim Simons's ClearPoint Neuro position peaked at $1.64M in Q4 2025.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.